Results Press Release for March 31, 2016
Piramal Enterprises Ltd has informed BSE about : 1. Result Press Release for the period ended March 31, 201616-05-2016
16-05-2016
Outcome of Board Meeting
Piramal Enterprises Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 16, 2016, inter alia, has not recommended any Final Dividend on the equity shares and the Interim Dividend declared by the Board of Directors at its meeting held on March 09, 2016 is recommended as Final Dividend.16-05-2016
Announces Q4 & FY16 Results (Standalone & Consolidated), Form A (Standalone & Consolidated) & Auditors Report (Standalone & Consolidated) for the period ended March 31, 2016
Piramal Enterprises Ltd has informed BSE that has announced the following results for the quarter & year ended March 31, 2016:The Unaudited Standalone results for the Quarter ended March 31, 2016The Company has posted a net profit of Rs. 2351.90 million for the quarter ended March 31, 2016 as compared to Rs. 726.90 million for the quarter ended March 31, 2015. Total Income has increased from Rs. 7100.20 million for the quarter ended...16-05-2016
Piramal Enterprises enters an agreement to acquire four brands from Pfizer Limited for its Consumer Products Business
Piramal Enterprises Ltd has informed BSE regarding a Press Release dated May 13, 2016 titled "Piramal Enterprises enters an agreement to acquire four brands from Pfizer Limited for its Consumer Products Business".13-05-2016
Nandini Piramal overhauls HR as group takes wing into newer territories
MUMBAI: When Nandini Piramal took up the mantel of Human Resources department at Piramal Group in August 2010, just a few months after father Ajay Piramal decided to sell most of the pharmaceutical business to Abbott, she found the department spending more time on sorting employee paperwork than on talent development. Piramal knew that for Piramal to grow talent was indispensible. She changed the team by replacing old with young. She formed the learning and development function, compensation and benefits function and a central talent sourcing team to begin with. She also got in more technology to reduce the manual paperwork. "After the Abbott deal we had to reinvent ourselves. I think our focus on people and talent development has also changed. We are integrating the science of HR a little bit more in what we are trying to do. We are helping each business recruit and develop the best talent," Piramal said. The $4 billion group, which was once a pure play pharmaceutical company, is now also spread across finance, real estate and information management. The business house is planning to demerge publicly listed Piramal Enterprises' healthcare and finance entities into independent companies. It is looking to get into...12-05-2016
FY16 results on May 16, 2016
Piramal Enterprises Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 16, 2016, to consider and approve the Audited Financial Results (Consolidated and Standalone) of the Company for the financial year ended March 31, 2016.In this regard, the Trading Window for dealing in the securities of the Company will remain closed from May 10, 2016 to May 18, 2016 (both days inclusive) i.e. after 48 hours...09-05-2016
Payment of Interest
Piramal Enterprises Ltd has informed BSE regarding "Payment of Interest".03-05-2016
Piramal Enterprises invests Rs 256.5 cr in Sanghi Industries
Piramal Enterprises today said it has invested Rs 256.5 crore in Sanghi Industries by subscribing to the cement maker's non-convertible debentures.21-04-2016
Shareholding for the Period Ended March 31, 2016
Piramal Enterprises Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click here21-04-2016